A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib
Titel:
A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib
Auteur:
Moran, Teresa Palmero, Ramón Provencio, Mariano Insa, Amelia Majem, Margarita Reguart, Noemí Bosch-Barrera, Joaquim Isla, Dolores Costa, Enric Carcereny Lee, Chooi Puig, Marta Kraemer, Sandrine Schnell, David Rosell, Rafael